References
- Feeley T W., Mihm F G., Downing T P., et al. The effect of hypothermic preservation of the heart and lungs on cardiorespiratory function following canine heart-lung transplantation. Ann Thorac Surg. 1985; 39: 558–562
- Kontos G J., Adachi H, Borkon A M., et al. A no-flush, core-cooling technique provides successful cardiopulmonary preservation for heart-lung transplantation. J Thorac Cardiovasc Surg 1987; 94: 836–842
- Robicsek F, Duncan G D., Masters T N., et al. The autoperfusion pressure-stabilized heartlung preparation: hemodynamic function after 20 hours of perfusion. Transplant Proc. 1988; 20: 991–993
- Starling E H. Principals of Human Physiology. Lea & Febiger, Philadelphia 1962; 713–714
- Demikhov V P. Experimental Transplantation of Vital Organs: Official Translation from Russian. Consultant Bureau, New York 1962
- Hardesty R L., Griffith B P. Autoperfusion of the heart and lungs for preservation during distant procurement. J Thorac Cardiovasc Surg. 1987; 93(1)11–18
- Hales C A., Sonne L, Peterson M B., et al. Role of thromboxane and prostacyclin in pulmonary vasomotor changes after endotoxin in dogs. J Clin Invest. 1981; 68: 497–505
- , Guide for the care and use of laboratory animals. NIH publication No. 80–23, revised 1978
- Said S I., Foda H D. Pharmacologic modulation of lung injury. Am Rev Respir Dis. 1989; 139: 1553–1564
- Sibille Y, Reynolds H Y. Macrophages and polymorphonuclear neutrophils in lung defense and injury. Am Rev Respir Dis. 1990; 141: 471–501
- Konstam M A., Hill N S., Bonin J D., et al. Prostaglandin mediation of hemodynamic responses to pulmonary microembolism in rabbits: effects of ibuprofen and meclofenamate. Exp Lung Res. 1988; 12: 331–345
- Martin B A., Wright J, Thommassen H, et al. Effects of pulmonary blood flow on the exchange between the circulating and marginating pool of polymorphonuclear leukocytes in dog lungs. J Clin Invest. 1982; 69: 1277–1285
- Cavarocchi N C., Pluth J R., Schaff H V., et al. Complement activation during cardiopulmonary bypass: comparison of bubble and membrane oxygenators. J Thorac Cardiovasc Surg. 1986; 91: 252–258
- Kirklin J K., Westaby S, Blackstone E H., et al. Complement and the damaging effects of cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1983; 86: 845–857
- Mashburn J P., Kontos G J., Hashimoto K, et al. The role of neural and vasoactive mediators in the regulation of the pulmonary circulation during cardiopulmonary preservation. J Thorac Cardiovasc Surg. 1989; 98: 434–443
- Mueller-Eberhard H J., Schreber R D. Molecular biology and chemistry of the alternate pathway of complement. Adv Immunol. 1980; 29: 1–53
- Ford-Hutchinson A W., Bray M A., Doig M W. Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes. Nature 1980; 286: 264–265
- Murphy R C. Biosynthesis and metabolism. Prostaglandins in Clinical Practice, W D. Watkins. Raven, New York 1989; 1–20